Archive · 4 Nov 2025
Pine Labs Head Favors Ebitda Over PAT for Company Valuation
Imagine a company called Pine Labs that helps businesses with payments.
Their boss, Amrish Rau, thinks that one way to measure how well the company is doing financially, called Ebitda, is more important than another way, called PAT.
Ebitda looks at how much money the company makes from just its main business operations, before considering things like taxes or big equipment costs.
Pine Labs has been making money this way for five years straight.
Their sales have been growing a lot, and the profit from operations has also increased a lot.
While they recently made a small profit after all costs, Mr. Rau isn't sure when that will happen consistently.
He believes that Ebitda is a better indicator of the company's actual worth, especially as they get ready to sell shares to the public in an IPO.
The company has also reduced the number of shares offered in the IPO, as investors are choosing to hold onto their shares, seeing good future potential.
Pine Labs has strong support from everyone involved with their business.
Pine Labs Chairman Amrish Rau believes Ebitda is a better measure of company value than Profit After Tax (PAT) for the upcoming IPO.
Rau states Pine Labs has been adjusted Ebitda positive for five consecutive years, with revenue growing over 20% annually for three years.
The company's adjusted Ebitda margin increased to around 20% in the first fiscal quarter.
Pine Labs recently reported its first quarterly net profit of over ₹4 crore, though overall net loss narrowed in FY25.
The company has reduced its IPO size due to existing investors choosing to sell fewer shares, signaling confidence in future growth.
- Who
- Pine Labs, led by Chairman and CEO Amrish Rau
- What
- Pine Labs' chairman advocates for Ebitda as a superior metric for valuing the company over Profit After Tax (PAT), highlighting the company's consistent Ebitda positivity and revenue growth.
- When
- The discussion around valuation metrics occurs as Pine Labs prepares for its IPO, with the company having reported its first quarterly profit in April-June and awaiting second quarter earnings.
- Where
- The company is based in India and has clients in Australia, Southeast Asia, West Asia, and the US.
- Why
- Amrish Rau believes Ebitda better reflects operational performance and thus the true value of Pine Labs, especially as the company aims to qualify for public listing based on its financial transition and growth.
Amrish Rau's Stance
General Investor Perspective (as described by EY Partner)
Preferred Valuation Metric
Amrish Rau's Stance
Ebitda is a better measure of Pine Labs' value as it focuses on operational performance and the company has a strong track record of adjusted Ebitda positivity.
General Investor Perspective (as described by EY Partner)
Investors increasingly emphasize a company's ability to generate cash from operations; long-term debtors or negative working capital are red flags. The focus has shifted from topline growth to sustainable business models where revenue translates into earnings.
Profitability Timeline
Amrish Rau's Stance
Uncertainty exists regarding when the company will achieve sustainable Profit After Tax (PAT) positive status.
General Investor Perspective (as described by EY Partner)
While PAT includes all expenses, the ultimate goal for investors is sustainable profitability, which implies positive PAT and cash flow generation.
Debt Management
Amrish Rau's Stance
The company's debt-equity ratio is fine, and there's no rush to reduce debt; proceeds are preferred for growth and business expansion.
General Investor Perspective (as described by EY Partner)
Long-term debtors or negative working capital are seen as red flags by investors, indicating a preference for deleveraging or strong cash flow to manage debt.
- Company
- Pine Labs
- Chairman & MD & CEO
- Amrish Rau
- Financial Metric Emphasis
- Ebitda (Earnings Before Interest, Taxes, Depreciation, and Amortization)
- Historical Ebitda Performance
- Adjusted Ebitda positive for five consecutive years
- Revenue Growth
- Over 20% for the last three years
- Adjusted Ebitda Margin (Q1 FY)
- Rose from single digit to around 20%
- Recent Net Loss
- Narrowed to approx. ₹140 crore in FY25 from over ₹300 crore in FY24
- First Quarter Net Profit
- Over ₹4 crore